NASDAQ
Proto Script Pharmaceutical Corp. (PSCR) has a free cash flow growth of 78.59% as of Friday, May 29, 2026. This represents a 146.50% increase compared to its 12-month average of -169.02%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.